Table 3.
Distribution of pulmonary, ophthalmic and dermatologic complications in several studies in Iran
| Reference | First author | After exposure time (years) | Agent | Under studied population | Number | Ocular complications (%) | Pulmonary complications (%) | Dermatologic complications (%) |
|---|---|---|---|---|---|---|---|---|
| [30] |
Khateri |
13 - 20 |
Mustard |
Veterans |
34000 |
93.3 |
42.5 |
24.5 |
| [30] |
Khateri |
14 |
Mustard |
Children |
50 |
86 |
100 |
98 |
| [31] |
Ghassemi Broumand |
19 |
Mustard |
Civilian population |
600 |
37.7 |
45.8 |
31.5 |
| [32] |
Balali Mood |
3 - 9 |
Mustard + Nerve agents |
Veterans |
1428 |
88 |
90 |
78 |
| [10] |
Ghassemi Broumand |
17 - 22 |
Various chemical agents |
Militaries + civilian |
479 |
26 |
32.1 |
23.3 |
| [33] |
Etezad Razavi |
16 - 20 |
Mustard |
Veterans |
40 |
65 |
95 |
90 |
| [15] |
Ghanei |
15 |
Mustard |
Civilian population |
108 |
* |
100 |
* |
| [34] | Emadi | 14 - 20 | Mustard + Nerve agents | Veterans | 800 | * | * | 100 |